| Drug Name |
Erythromycin stearate |
| Drug ID |
BADD_D00807 |
| Description |
Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245] |
| Indications and Usage |
For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to Corynebacterium diphtheriae, in the treatment of infections due to Corynebacterium minutissimum, intestinal amebiasis caused by Entamoeba histolytica, acute pelvic inflammatory disease caused by Neisseria gonorrhoeae, skin and soft tissue infections of mild to moderate severity caused by Streptococcus pyogenes and Staphylococcus aureus, primary syphilis caused by Treponema pallidum, infections caused by Chlamydia trachomatis, nongonococcal urethritis caused by Ureaplasma urealyticum, and Legionnaires' disease caused by Legionella pneumophila. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
D10AF02; J01FA01; S01AA17 |
| DrugBank ID |
DB00199
|
| KEGG ID |
D02184
|
| MeSH ID |
C011462
|
| PubChem ID |
12559
|
| TTD Drug ID |
D02YIZ
|
| NDC Product Code |
55289-112; 52334-002; 66639-003; 24338-106 |
| Synonyms |
erythromycin stearate | gallimycin |
